Novel Tool to Monitor Adherence to Oral Oncolytics: A Pilot Study.

Wendy SunRebecca ReeveTimothy OuelletteMartha StutskyRachel De JesusMichael J HufferSarah S Mougalian

Published in: JCO clinical cancer informatics (2021)

This novel technology is able to monitor, measure, and intervene for patients taking capecitabine in real time. Adherence overall was high, and some patients appeared to benefit more from text-message interventions. Future work should focus on patients deemed high risk for nonadherence.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
randomized controlled trial
radiation therapy
adipose tissue
patient reported
rectal cancer
phase ii study
open label
phase iii